The Journey to EU MDR/ IVDR Compliance: Key Lessons and Considerations
The journey so far
Year 2017 was a learning phase for the Medical Device industry. With the official launch of the European Medical Device Regulations (EU MDR 2017/745) and European In-Vitro Diagnostic Regulations (EU IVDR 2017/746), many medical device and in-vitro diagnostic companies faced uncertainty and confusion over the new requirements, as well as risks and challenges to their business.
With few exceptions, I have seen most large manufacturers establish a program management (PMO) team and roping in top management consulting companies to help determine the impact on their business and revenues. Small and mid-size companies are working with regulatory consultants to understand the new requirements.
The second half of the last year was mostly spent on awareness sessions, workshops, gap assessment pilots and budget planning. I have spoken to many program directors to understand their strategy, budget and plan for the next two to three years, and led or participated in many knowledge sessions and workgroups. I have learned a great deal so far, and hope to share some of that with you today.
- Simplify program management by creating a 360° view dashboard for each product family. This dashboard should include parameters like revenue, markets, risks, technical files, labels/IFUs, authorized representative, notified body, manufacturing sites, economic operators, QMS, etc., along with your key stakeholders from various functions.
- Remove redundancy and organize technical files and design dossiers for each product family in a centralized repository.
- Digitize high-value legacy records and technical documents for gap assessment, inspection readiness and easy availability.
- Plan ahead for your organization-wide implementation or upgrade to QMS ISO EN 13485:2016, MEDDEV 2.7.1 rev.4, UDI, eIFU Website (Content Management Framework).
- Prioritize the remediation of technical files for products with high business impact and complexity.
- Evaluate and onboard service providers early in the program to improve the success rate and on-time completion.
- Build an agile platform that enables internal and external stakeholders to engage and collaborate on a day-to-day basis.
- Implement tools and accelerators to improve visibility, tracking, quality and productivity across workstream projects and your overall program.
While the industry is waiting for the re-designation of the Notified Bodies, most manufacturers have completed the impact and gap assessment of key technical files and are currently planning for technical file remediation. Keep in mind that if you have a high volume of technical documents, or they are complex, in legacy formats, or not well-controlled or documented under the same product family, remediation will require much more advance planning.
Key considerations for technical file remediation
|Reformatting GHTF Summary Technical Documentation (STED)||
|General Safety and Performance Requirements Checklist||
|Declaration of Conformity||
It requires extremely careful planning and monitoring of different workstreams to successfully remediate technical files. By identifying critical success factors, risks and challenges early on, your planning will be easier and the chances of a “first-time-right” remediation program improve dramatically. By setting-up a digital PMO dashboard, QC checklists, tools and accelerators, you can help ensure a much smoother transition to EU MDR/ IVDR compliance.
Sourav Gupta has 14+ years of experience supporting the Life Sciences industry in the clinical, quality, regulatory and information technology areas. He is currently leads Syntel’s Medical Device practice and is working with several global Medical Device clients on EU MDR/ IVDR compliance. He can be contacted at Sourav_Gupta@syntelinc.com.